- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05799352
Effects of Endoscopic Lung Volume Reduction on Diaphragm Function and Conformation
August 5, 2025 updated by: Olivier Taton, Erasme University Hospital
Chronic obstructive lung disease (COPD) is a common disease that is frequently complicated by hyperinflation.
The resulting increase in lung volume impairs the diaphragmatic function because of a shortening of the diaphragmatic fibers and an increase in the radius of curvature of the diaphragmatic domes.
Lung volume reduction surgery (LVRS) has already shown an improvement in diaphragmatic function that could be explained by a change of the diaphragm conformation.
More recently, endoscopic lung volume reduction (ELVR) has shown benefits in terms of respiratory function, exercise capacity and quality of life, but the mechanisms of these improvements are poorly understood.
Therefore, we aim to evaluate the evolution of the diaphragmatic function and the changes in diaphragmatic conformation after unilateral ELVR.
Study Overview
Study Type
Interventional
Enrollment (Actual)
35
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Brussels, Belgium, 1070
- Erasme Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- valves insertion
Exclusion Criteria:
- TLVR < 50 %
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Endoscopic lung volume reduction
All the patients will have endobronchial valves insertion.
We will evaluate before and 3 months after the evolution of the diaphragmatic strength and conformation.
|
a prospective monocentric study on hyperinflated COPD patients without collateral ventilation.
Patients were evaluated before and 3 months after unilateral ELVR by transdiaphragmatic pressure (Pdi) measured at the functional residual capacity (FRC) after magnetic phrenic stimulation and by high-resolution computed tomography at the FRC allowing 3D modelling of the diaphragm for measurements of fibers length, length of the zone of apposition and radius of curvature of the diaphragmatic domes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Transdiaphragmatic pressure
Time Frame: before until 3 months after the valves insertion
|
evaluate the difference in diaphragmatic function, assessed by the transdiaphragmatic pressure, before and 3 months after unilateral valves setting
|
before until 3 months after the valves insertion
|
|
Diaphragmatic conformation
Time Frame: before until 3 months after the valves insertion
|
evaluate the change of the diaphragm conformation, by measuring diaphragmatic fibers length in several planes, diaphragmatic area and radius of curvature, before and 3 months after unilateral ELVR.
|
before until 3 months after the valves insertion
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Olivier Taton, Hôpital Erasme, Université Libre de Brussels, Brussels, Belgium
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2019
Primary Completion (Actual)
January 30, 2025
Study Completion (Actual)
January 30, 2025
Study Registration Dates
First Submitted
March 23, 2023
First Submitted That Met QC Criteria
March 23, 2023
First Posted (Actual)
April 5, 2023
Study Record Updates
Last Update Posted (Actual)
August 11, 2025
Last Update Submitted That Met QC Criteria
August 5, 2025
Last Verified
August 1, 2025
More Information
Terms related to this study
Other Study ID Numbers
- P2018/227
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on COPD
-
University Medical Center GroningenCompleted
-
Ryme Medical, Inc.Not yet recruitingCOPD | Lung Disease, Chronic Obstructive | COPD Patients | COPD Acute Exacerbation | COPD (Chronic Obstructive Pulmonary Disease) | Lung Disease Airways | COPD Exacerbations
-
Insel Gruppe AG, University Hospital BernUniversity Hospital, Geneva; Cantonal Hospital St. Gallen, SwitzerlandNot yet recruiting
-
Istituto Nazionale di Ricovero e Cura per AnzianiRecruiting
-
Bio-Sensing Solutions S.L. (DyCare)Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau; Centre...Recruiting
-
Sir Run Run Shaw HospitalRecruiting
-
The First Affiliated Hospital of Guangzhou Medical...Recruiting
-
Association des Réseaux BronchioliteLaboratoire Système et Matériaux pour la Mécatronique (SYMME)Recruiting
-
Polytechnic Institute of PortoNippon Gases PortugalRecruiting
-
China-Japan Friendship HospitalNot yet recruiting
Clinical Trials on Endoscopic lung volume reduction
-
Assaf-Harofeh Medical CenterUnknown
-
Universitätsklinikum Hamburg-EppendorfTerminated
-
University Hospital, LimogesRecruiting
-
Pulmonx CorporationCompletedCOPD | Heterogeneous EmphysemaNetherlands, Sweden, United Kingdom, Germany, France, Belgium
-
Universität Duisburg-EssenRecruiting
-
Boston Scientific CorporationPneumRx, Inc.CompletedEmphysemaNetherlands, Germany, France
-
Boston Scientific CorporationPneumRx, Inc.CompletedEmphysemaGermany, Netherlands
-
Boston Scientific CorporationPneumRx, Inc.Completed
-
RWTH Aachen UniversityUnknownChronic Obstructive Pulmonary Disease (COPD)Germany
-
University Medical Center GroningenCompletedEmphysema | COPDNetherlands